T-Cypher Bio Holdings Limited
T-Cypher Bio is dedicated to developing innovative TCR-based therapeutics aimed at transforming the treatment of immune-mediated diseases, particularly in oncology. Their proprietary platforms enable high-resolution profiling of T cell specificity, paving the way for groundbreaking immunotherapies.
Founded: 28 Aug 2020
Industries:
72110 - Research and experimental development on biotechnology
Website: tcypherbio.com
Location: Oxford
Products & Services
• biotechnology
• computational modeling of t cell repertoires
• high throughput immune profiling platforms
• immune mediated diseases
• immunotherapy
• novel tcr-based immunotherapies for oncology
• oncology
• t cell biology
• tcr based therapeutics
• tcr-based therapeutics development
Financial Snapshot
Cash in Bank
Turnover
EBITDA
Gross Profit
Total Liabilities
Employees
Unlock financial data with Pro Start Free Trial →
People
Officers
4
Shareholders
26
Controllers (PSC)
1
Claire Brown
Director • British • Lives in England • Born in May 1971
Thomas Lars Andresen
Director • Danish • Lives in Denmark • Born in Oct 1972
Shyam Masrani
Director • British • Lives in England • Born in Jan 1990
Owen Hughes
Director • American • Lives in United States • Born in Sept 1974
Registered Office Address
3rd Floor, The Sherard Building Edmund Halley Road
The Oxford Science Park
Oxford
OX4 4DQ
United Kingdom
Basic Information
LTD
28 Aug 2020
ENGLAND WALES
Yes
Industry Classification
72110
Company Attributes
N/A
N/A
N/A
N/A
Summary
9
Officers
1
PSCs
0
Filings